A huge cervical myoma (rare) in a young woman is a nightmare of every gynecologist owing to the associated technical challenges in performing a myomectomy. Moreover, the 2014 US Food and Drug Administration prohibited power morcellation during laparoscopic myomectomy due to the inadvertent spread of occult malignancy and an increased risk of iatrogenic parasitic leiomyoma negatively affected the overall rate of a minimally invasive surgery. Case: This report described our experience with a case of a huge anterior cervical myoma (473 gr) in a young nulligravida woman who successfully underwent laparotomic myomectomy. After an initial diagnosis by Magnetic resonance imaging (MRI), we performed preoperative ureteric catheterization. The myoma was enucleated following the footsteps of Victor Bonney, the pioneer of myomectomy, combined with simple additional steps. We did not use preoperative gonadotropin-releasing hormone analog, intraoperative vasopressin injection, or uterine artery ligation. A 6month follow-up MRI revealed an intact cervical canal in midline position with no evidence of residual fibroid. Conclusion: Based on our experience, the review of the relevant literature, and the US Food and Drug Administration's prohibition of power morcellation during laparoscopic myomectomy, a laparotomic myomectomy for a huge cervical myoma still plays a vital role in fertility preservation. We propose the mnemonic "MUSIC" as a helpful guide for a consistent strategy: M (preoperative MRI), U (prophylactic ureteric catheterization), S (shell out the myoma following Bonney's principles i.e. start-up and stay intracapsular), I (immediate suction to clarify dead space) and C (close the cavity by spiraling stitch). How to cite this article: Abu Hashim H, Al Khiary M, EL Rakhawy M. "Laparotomic myomectomy for a huge cervical myoma in a young nulligravida woman: A case report and review of the literature," Int J Reprod BioMed 2020; 18: 135-144. https://doi.Production and Hosting by Knowledge E Abu Hashim et al. This article is distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use and redistribution provided that the original author and source are
Introduction
Cervical myomas are rare and accounts for 0.6% of all uterine fibroids (1) . Magnetic resonance imaging (MRI) is the eminent modality for its detection. Large cervical fibroids could be identified on T2-weighted sagittal imaging and categorized as either extra cervical (i.e., subserosal that may be anterior, posterior, or lateral) or intracervical (i.e., intramural) (2) . Unlike Recently, the US Food and Drug Administration prohibited the retrieval of myoma by power morcellation during laparoscopy (5) .
The primary objective of this report is to describe our experience with a case of a huge anterior cervical myoma in a young nulligravida woman who successfully underwent laparotomic myomectomy to preserve her fertility. In addition, we carried out a review of the relevant literature. 
Case Report

Patient information and clinical findings
Diagnostic assessment
Her lab profile values were within the normal limits of hemoglobin: 13.3 g/dL. Ultrasonography revealed a huge pelvic mass that measured 11 × 12 cm (probably of uterine origin). MRI revealed a huge anterior cervical myoma measuring 10.5 × 9.2 × 12 cm (anteropsterior, transverse, and height, respectively) with the uterine body visualized above and the fundus reaching 5 cm cranially to the sacral promontory ( Figure 1 ). Neither hydronephrosis nor hydroureter was detected by the IVP; however, the left ureter was mildly and laterally displaced.
Operative steps
The patient was counseled for surgery with a high possibility of a hysterectomy. Due to financial constraints, she did not receive preoperative gonadotropin-releasing hormone analog (GnRHa).
After an informed consent, prophylactic ureteric catheterization was performed. Exploratory laparotomy revealed a huge anterior cervical myoma that measured about 10.5 × 9 × 12 cm filling the pelvis with normal corpus uteri on its top and deviated backward to the right. Both fallopian tubes and ovaries were grossly normal.
Bilateral uterine artery ligation (BUAL) at its origin from the internal iliac artery (IIA) was not possible.
Myometrial injection of diluted vasopressin was
not performed due to non-availability of the drug in our country.
The peritoneal flap over the tumor was incised at its upper limit and, then, reflected downward.
The footsteps of Victor Bonney, the pioneer of myomectomy, were meticulously followed to shell out the myoma (6) . First, the capsule of the tumor was incised at its upper portion for about 5 cm. Then, the index finger of the left hand was inserted through the incision to ascertain the plane of cleavage between the tumor and its capsule.
Subsequently, the incision was enlarged across the capsule and the tumor was gradually enucleated down to its base by using the fingers of the right hand through the proper plane of cleavage. 
Follow-up and outcomes
The patient was regularly followed up monthly for about six months. Outcomes included the resumption of regular menses and symptom relief.
The patient reported regular menses and a relief of pelvic pressure symptoms. A six-month follow-up MRI revealed an intact cervical canal in the midline position with no evidence of residual fibroids ( Figure 3 ). Figure 4 presents the relevant data from this episode of care organized as a timeline. c. The wound edges are being pulled up by forceps and suction to clarify the tumor bed. d. The cavity is obliterated by continuous concentric layers of "spiraling stitch." e. Schematic presentation of the "spiraling stitch." f. A "baseball stitch" is inserted to close the superficial wound edges after its trimming. g. Schematic presentation of the "baseball stitch." Follow-up MRI
Ethical consideration
x The patient reported regular menses and relief of pelvic pressure symptoms. 
Discussion
Abdominal myomectomy should be the standard fertility preservation procedure of choice for cervical fibroids in women who desire to preserve their fertility. We Measures utilized to minimize the intraoperative blood loss include BUAL at its origin from the IIA and intraoperative injection of diluted vasopressin into the myoma (4, 8) . BUAL at its origin was carried out in two LCM case series (8, 9) . The mean maximum diameter of the excised myomas was 8.5 cm and its median weight was 220 gr in one series (9) and ranged between 99.3 and 306.2 gr in the other one (8) . In our case, we were not able to perform BUAL at its origin, because the huge fibroid (473 gr) was completely filling the pelvic cavity, thereby restricting access to the pelvic sidewall dissection. This difficulty was also recognized in LCM for the large myomas of greater than 250 gr, and BUAL was only achieved after the downsizing of myoma by partial enucleation and morcellation (4) . Unlike other research works (4, 8) , the intraoperative injection of diluted vasopressin into the myoma was not carried out in our case due to non-availably of this medication in our country.
The estimated blood loss in our case was 150 mL. Chang and colleagues (4) these concerns negatively affected the overall rate of minimally invasive surgery (10) . Therefore, a laparoscopic myomectomy for our case (myoma of 473 gr) is not advisable because it will not be achieved except after its initial downsizing by partial enucleation and morcellation followed by shelling out of the remaining part and its morcellation. The gynecologic surgeon should make a diligent effort in following these technical principles that are the mainstay to avoid intraoperative urological injuries and massive hemorrhage.
Conclusion
